Journal of Biological Chemistry · 2012 · 61 citations · 57 references
Life SciencesBiochemistryMedicinal ChemistryDrug DiscoveryStructural BiologyStructure-activity RelationshipsAmyloid FormationBioactive Small MoleculesEnzyme InhibitionLigand BindingMolecular DockingProtein StructureAmyloid Beta AggregationAmyloid Fibril FormationAmyloid FibrillogenesisAmyloid FibrilsAmyloid InhibitionAmyloid Oligomer FormationInhibition Of Amyloid Formation
Increasing evidence implicates Aβ peptides self-assembly and fibril formation as crucial events in the pathogenesis of Alzheimer disease. Thus, inhibiting Aβ aggregation, among others, has emerged as a potential therapeutic intervention for this disorder. Herein, we employed 3-aminopyrazole as a key fragment in our design of non-dye compounds capable of interacting with Aβ42 via a donor-acceptor-donor hydrogen bond pattern complementary to that of the β-sheet conformation of Aβ42. The initial design of the compounds was based on connecting two 3-aminopyrazole moieties via a linker to identify suitable scaffold molecules. Additional aryl substitutions on the two 3-aminopyrazole moieties were also explored to enhance π-π stacking/hydrophobic interactions with amino acids of Aβ42. The efficacy of these compounds on inhibiting Aβ fibril formation and toxicity in vitro was assessed using a combination of biophysical techniques and viability assays. Using structure activity relationship data from the in vitro assays, we identified compounds capable of preventing pathological self-assembly of Aβ42 leading to decreased cell toxicity.
57
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
Ulrich K. Laemmli · Nature · 1970 · 251.6K citations
How to measure and predict the molar absorption coefficient of a protein
C. Nick Pace, F.F. Vajdos, Lanette Fee et al. · Protein Science · 1995 · 3.9K citations · Full text